Synthesis ofN-Glycosylated Pyridiines as New Antimetabolite Agents
摘要:
Condensation of cyanoacetamide and cyanothioacetamide with the sodium salts of alpha-(hydroxymethylene)alkanones afforded the pyridine-2(1H)-ones and their corresponding thiones 3. Compounds 3 served as a key intermediates for the synthesis of N-glycosylated pyridines.
Synthesis ofN-Glycosylated Pyridiines as New Antimetabolite Agents
摘要:
Condensation of cyanoacetamide and cyanothioacetamide with the sodium salts of alpha-(hydroxymethylene)alkanones afforded the pyridine-2(1H)-ones and their corresponding thiones 3. Compounds 3 served as a key intermediates for the synthesis of N-glycosylated pyridines.
The invention relates to novel substituted 2-(phenyl-, pyridyl- or pyrimidyl-carbonyl)-furanes and -thiophenes and related phenoxy/phenylthio-acetophenones and corresponding heterocyclic compounds, processes for the preparation thereof, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more other pharmaceutically active compounds for the therapy of neoplastic diseases and autoimmune diseases, and a method for the treatment of such a diseases.
Aryloxy- and arylthioxyacetophenone-type compounds for the treatment of cancer
申请人:Basilea Pharmaceutica AG
公开号:EP1894917A1
公开(公告)日:2008-03-05
The invention relates to compounds of formula (II)
wherein ring A is a phenyl, pyridine, pyrimidine or pyrazine ring, W and X are carbon or nitrogen, Y is oxygen or sulfur, R0 is different from hydrogen, Rx is -(C=O)R1 or cyano; R1 is hydrogen, optionally substituted hydroxy or optionally substituted amino, and the other substituents are as described in the specification. The invention further relates to methods of synthesis of such compounds, to pharmaceutical compositions containing compounds of formula (II), to the use of a compounds of formula (II) for the preparation of a pharmaceutical composition for the treatment of neoplastic and autoimmune diseases, and to methods of treatment of neoplastic and autoimmune diseases using compounds of formula (II) or pharmaceutical compositions containing same.
本发明涉及式 (II) 的化合物
其中环 A 是苯基、吡啶、嘧啶或吡嗪环,W 和 X 是碳或氮,Y 是氧或硫,R0 不同于氢,Rx 是-(C=O)R1 或氰基;R1 是氢、任选取代的羟基或任选取代的氨基,其他取代基如说明书所述。本发明进一步涉及合成此类化合物的方法,涉及含有式(II)化合物的药物组合物,涉及使用式(II)化合物制备治疗肿瘤性和自身免疫性疾病的药物组合物,以及涉及使用式(II)化合物或含有式(II)化合物的药物组合物治疗肿瘤性和自身免疫性疾病的方法。
?-Ketoaldehydes in the synthesis of 6-alkyl-3-cyano-2(1H)-pyridinethiones
作者:N. G. Frolova、V. K. Zav'yalova、V. P. Litvinov
DOI:10.1007/bf00698508
日期:1995.4
An efficient synthesis of 6-alkyl-3-cyano-2(1H)-pyridinethiones by the reactions of the sodium salts of beta-ketoaldehydes with cyanothioacetamide was developed. Pyridinethiones undergo selective S-alkylation with haloacetonitriles and haloacetophenones followed by cyclization to the corresponding thieno[2,3-b] pyridines.
[EN] AROYLFURANES AND AROYLTHIOPHENES<br/>[FR] FURANES D'ARYLE ET THIOPHENES D'ARYLE